A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

NCT07218627 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: NNC0537-1482
DRUG: Placebo

Sponsor

Novo Nordisk A/S